Evidence map›Paper›PMID 40918942›Full record

ArticleInternational journal of nanomedicine2025

Gold/Prussian Blue-Based Nanocomposites with Dual Nanozyme Activities Exert a Synergistic Effect of Starvation Therapy and Sonodynamic Therapy in the Treatment of Liver Cancer.

Shengnan Huang, Chengzhi Song, Tengyue Zhao, Yefei Yang, Zhiwei Yao, Shaofeng Duan, Wanyi Chen, Lixian Li, Xiaogang Hu, Chunming Li and 1 more

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shengnan Huang *Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China.ORCID 0000-0003-2566-4324
Chengzhi Song *Center for Quantitative Biology, Peking University, Beijing, 100871, People's Republic of China.
Tengyue Zhao *School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.
Yefei YangSchool of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.
Zhiwei YaoSchool of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.
Shaofeng DuanSchool of Pharmaceutical Sciences, Henan University, Zhengzhou, 450046, People's Republic of China.ORCID 0000-0003-2151-082X
Wanyi ChenDepartment of Pharmacy, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Lixian LiDepartment of Pharmacy, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Xiaogang HuDepartment of Pharmacy, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Chunming LiDepartment of Pharmacy, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Yurong HuSchool of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to develop a composite nanozyme system (Au/PB-Ce6-HA) based on gold nanoparticles (AuNPs) and Prussian blue nanoparticles (PBNPs) to combat tumor hypoxia and insufficient endogenous hydrogen peroxide (H Methods: The Au/PB-Ce6-HA system was constructed by in situ embedding AuNPs on PBNPs, loading the sonosensitizer Chlorin e6 (Ce6), and surface-coating with thiolated hyaluronic acid (HA-SH). The system was evaluated both in vitro and in vivo to assess its ability to catalyze glucose to generate H Results: The Au/PB-Ce6-HA nanozymes demonstrated high catalytic activity, thus significantly improving SDT and starvation therapy. Specifically, the system effectively deprived tumors of their energy supply by generating H Conclusion: An intelligent composite nanomaterial was successfully developed, combining starvation therapy and sonodynamic therapy to significantly enhance the treatment of liver cancer. The Au/PB-Ce6-HA nanozyme system demonstrated excellent synergy in both in vitro and in vivo settings, offering a promising strategy for cancer therapy.

Indexed as

FerrocyanidesGoldLiver NeoplasmsMetal NanoparticlesNanocompositesUltrasonic TherapyAnimalsCell Line, TumorChlorophyllidesHumansHyaluronic AcidHydrogen PeroxideMiceMice, Inbred BALB CMice, NudePorphyrinsChlorophyllidesferric ferrocyanideFerrocyanidesGoldHyaluronic AcidHydrogen PeroxidephytochlorinPorphyrinsReactive Oxygen Speciescomposite nanozymegold nanoparticlesPrussian blue nanoparticlessonodynamic therapystarvation therapy

Identifiers

PMID40918942
PMCPMC12412767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.